Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Richard Scheller
Age : 67
Public asset : 3,219,909 USD
Country of residence : Unknown
Linked companies : 23andMe Holding Co. - BridgeBio Pharma, Inc. - Alector, Inc. - DICE Therapeutics, Inc. - ORIC Pharmaceuticals, Inc.

Biography of Richard Scheller 
Dr. Richard H. Scheller is an Independent Director at Alector, Inc., a Director, Chairman-Research & Development at BridgeBio Pharma LLC, an Independent Director at Oric Pharmaceuticals, Inc., a Chairman at DICE Molecules SV LLC, a Director, Chairman-Research & Development at BridgeBio Pharma, Inc., a Member at American Academy of Arts & Sciences, a Member at National Academy of Medicine of United States and a Member at National Academy of Sciences. He is on the Board of Directors at Maze Therapeutics, Inc., Alector, Inc., BridgeBio Pharma LLC, DiCE Molecules, Inc., 23andMe, Inc., Oric Pharmaceuticals, Inc., Dice Molecules Holdings LLC, Rafael Pharmaceuticals, Inc., BridgeBio Pharma, Inc. and Fine Arts Museums of San Francisco. Dr. Scheller was previously employed as an Independent Director by Xenon Pharmaceuticals, Inc., a Director & Chief Scientific Officer by Medrio, Inc., a Head-Genentech Research & Early Development by Roche Holding AG, an Executive VP-Research & Early Development by Genentech, Inc., and an Associate Professor by Stanford University. He also served on the board at Affinita Biotech, Inc. He received his undergraduate degree from the University of Wisconsin, a doctorate degree from The Trustees of Columbia University in The City of New York and a doctorate degree from California Institute of Technology.


Current positions of Richard Scheller 
Holdings of Richard Scheller 
Richard Scheller : Personal Network 
Most Read News 
01/18ELON MUSK : Tesla investors urge judge to order Musk repay $13 billion for SolarCity deal
RE
01/11JAMIE DIMON : JPMorgan's Dimon says consumer loan growth may take 6-9 months to return to normal
RE
01/13JACK DORSEY : Jack Dorsey's Block to build an open bitcoin mining system
RE
01/14ELON MUSK : Musk says Tesla to accept dogecoin for merchandise
RE
01/10BRUNELLO CUCINELLI : Luxury group Cucinelli posts 31% sales jump in 2021
RE
01/11CATHIE WOOD : ARK's Wood turns focus to deflation, 'stay connected' stocks
RE
01/12MARTIN SORRELL : Sorrell's S4 says trading well ahead of guidance
RE
01/13AMANCIO ORTEGA : Inditex founder Amancio Ortega buys Toronto's Royal Bank Plaza for $916 mln
RE
01/07RICHARD BRANSON : British tycoon Branson to list blank-check firm in Amsterdam, Sky News says
RE
01/17ELON MUSK : Top Energy News of the Day
DJ
More news


© 2022 People and Ownership :   
Richard Scheller : Connections 


Latest news about Richard Scheller 
202123andMe, Inc. completed the acquisition of VG Acquisition Corp. from VG Acquisition Sponsor LLC and others in a reverse merger transaction.
CI
202123andMe, Inc. entered into a definitive merger agreement to acquire VG Acquisition Corp. from VG Acquisition Sponsor LLC and others in a reverse merger transaction for $5.8 billion.
CI
2020Xenon Pharmaceuticals Inc. Announces Management Changes
CI
2019BridgeBio Pharma, Inc. Announces Appointment of Jennifer Cook as Board Member
CI
2019Alector, Inc. Appoints Richard Scheller and Thomas Südhof as Co-Chairs of the Company’S Strategic Portfolio Advice and Review Committee
CI
2018Alector Announces Board Appointments
CI
2018GSK bets $300 million on genetics as CEO plays down break-up talk
RE
More news